The many intersecting pathways underlying apolipoprotein B secretion and degradation
about
The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathwaysRoad to ruin: targeting proteins for degradation in the endoplasmic reticulumTANGO1 and Mia2/cTAGE5 (TALI) cooperate to export bulky pre-chylomicrons/VLDLs from the endoplasmic reticulumStringent requirement for HRD1, SEL1L, and OS-9/XTP3-B for disposal of ERAD-LS substrates.Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function.Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?Insulin-stimulated degradation of apolipoprotein B100: roles of class II phosphatidylinositol-3-kinase and autophagyQuantity control of the ErbB3 receptor tyrosine kinase at the endoplasmic reticulumIncreased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance.Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat DietProtein disulfide isomerases contribute differentially to the endoplasmic reticulum-associated degradation of apolipoprotein B and other substratesCholesterol 27-hydroxylase but not apolipoprotein apoE contributes to A2A adenosine receptor stimulated reverse cholesterol transportDerlin-1 and UBXD8 are engaged in dislocation and degradation of lipidated ApoB-100 at lipid dropletsFatty acid regulation of hepatic lipid metabolism.Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases.The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study.Autophagy-mediated longevity is modulated by lipoprotein biogenesis.ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice.Substrate-specific mediators of ER associated degradation (ERAD).A regulator of secretory vesicle size, Kelch-like protein 12, facilitates the secretion of apolipoprotein B100 and very-low-density lipoproteins--brief report.Docosahexaenoic acid impairs the maturation of very low density lipoproteins in rat hepatic cells.Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.FoxO1 and hepatic lipid metabolism.Ectopic lipid storage and insulin resistance: a harmful relationship.Regression of Atherosclerosis: The Journey From the Liver to the Plaque and BackStable isotope-based flux studies in nonalcoholic fatty liver disease.Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia.Regulation of diacylglycerol acyltransferase 2 protein stability by gp78-associated endoplasmic-reticulum-associated degradation.A malfunction in triglyceride transfer from the intracellular lipid pool to apoB in enterocytes of SOD1-deficient mice.Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins.Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100.ERAD-dependent control of the Wnt secretory factor Evi.
P2860
Q26824858-A6BC5E91-A08C-4DA2-95A7-150859D46CDDQ26866096-424F8148-2751-4695-8242-3DAEFB4CFE5EQ28118978-FB623864-98F5-40B7-920A-9213BB9B0236Q33615098-AB682134-40A0-449F-A895-155C76CFF445Q34028751-DBC8338F-1364-45CE-8E1D-56A73D39CB8CQ34188082-57DA7BEA-FEE5-40C7-A3C2-7F59F0330F7CQ34395165-DC1DBBAC-3BB8-479F-80A1-6DDA06E36200Q34629362-90608851-C749-4966-9F2E-D29B1F9C2779Q35096647-60B096B7-C266-4D76-B71C-7984095C276DQ35186665-EEB504CE-ED45-47C7-A163-B72AB71E1870Q35602046-39CDEE83-15B7-4E65-873B-0F93FDEA46ACQ35756661-AAE3F5D5-E161-461A-849F-F66876BA2669Q35784786-D2FD74F3-6686-4AD1-855C-36D18B197481Q35790894-3D6C5D1F-FF46-4480-8553-2E1D3044302DQ35975409-DFD86180-62DD-46AF-96FE-BFEEA825D6BCQ36395865-926AD6E2-AFC9-4D22-B3D2-490D49239EEDQ36538113-E7B47CFC-EB65-4485-B087-4C1B3E854201Q36599680-90DF523C-25C0-418C-9EF9-22A5EA9B3553Q36810995-DB53EFA5-089E-41C9-99F2-65998350158FQ37132127-9CA61A1A-C8F3-4431-81F2-D116CA9659CAQ37374061-51054D24-A774-4E43-AD44-04A6916EA328Q37574080-730B9706-E949-4131-A03F-15D38AB4A13FQ37590265-3625A6ED-403D-405D-A8C7-ADE5CA5CDE72Q37705810-376149FC-C131-4819-8B3D-1BF354FE5E3CQ37805344-075AFE3A-887F-4070-8210-4A729C966B8DQ38095619-BB1FD62D-3B82-4FFD-A1C7-C20832A6E8E7Q38560870-8B698003-69A8-4CA4-9271-5981138E797BQ38655651-8DCD3F82-26DA-421F-A7B0-5E75B58A6552Q38969073-407C7110-AB30-4191-B0C0-C5D968F1A8DEQ38995770-5F4FE92C-466E-47DA-B4B0-6D5779BE5965Q44605628-38CBCE50-6667-48E1-B903-2BEC6B73FC35Q46252515-54CACD18-332C-4F08-AE58-EC4D108A925FQ47231484-836E90D9-8B80-4373-92F0-E32DE16AAB4BQ48148141-3C3B74B1-D55C-46A8-AD54-C149AFE4F04A
P2860
The many intersecting pathways underlying apolipoprotein B secretion and degradation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The many intersecting pathways underlying apolipoprotein B secretion and degradation
@en
The many intersecting pathways underlying apolipoprotein B secretion and degradation.
@nl
type
label
The many intersecting pathways underlying apolipoprotein B secretion and degradation
@en
The many intersecting pathways underlying apolipoprotein B secretion and degradation.
@nl
prefLabel
The many intersecting pathways underlying apolipoprotein B secretion and degradation
@en
The many intersecting pathways underlying apolipoprotein B secretion and degradation.
@nl
P2860
P1476
The many intersecting pathways underlying apolipoprotein B secretion and degradation
@en
P2093
Jeffrey L Brodsky
P2860
P304
P356
10.1016/J.TEM.2008.07.002
P577
2008-08-06T00:00:00Z